What is the enterprise value (EV) for Bio-Rad Laboratories, Inc. (BIO)?

The enterprise value (EV) for BIO stock is $9.35B.

Bio-Rad Laboratories (BIO) Enterprise Value: History & Chart

Bio-Rad Laboratories, Inc. (BIO)BIOBio-Rad Laboratories, Inc.

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA

7,450 employees

www.bio-rad.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Norman D. Schwartz

View full financials

NAME	MARKET CAP	ENTERPRISE VALUE (EV)
Bio-Rad Laboratories, Inc. (BIO)	$8.50B	$9.35B
Tempus AI, Inc. (TEM)vs ›	$7.47B	$8.27B
Oscar Health, Inc. (OSCR)vs ›	$7.31B	$2.93B
Henry Schein, Inc. (HSIC)vs ›	$9.74B	$13.35B
Universal Health Services, Inc. (UHS)vs ›	$9.75B	$14.76B
Molina Healthcare, Inc. (MOH)vs ›	$10.31B	$9.28B
Walgreens Boots Alliance, Inc. (WBA)vs ›	$10.37B	$38.64B
Hims & Hers Health, Inc. (HIMS)vs ›	$6.27B	$7.18B
Charles River Laboratories International, Inc. (CRL)vs ›	$10.91B	$13.78B
Bio-Techne Corporation (TECH)vs ›	$11.21B	$11.29B

NAME

MARKET CAP

ENTERPRISE VALUE (EV)

Bio-Rad Laboratories, Inc. (BIO)

$8.50B

$9.35B

Tempus AI, Inc. (TEM)vs ›

$7.47B

$8.27B

Oscar Health, Inc. (OSCR)vs ›

$7.31B

$2.93B